MedPage Today on MSN
What Are the Goalposts for Present and Future ATTR-CM Therapies?
This spring, the gene-silencing therapy vutrisiran (Amvuttra) joined the transthyretin (TTR) stabilizers tafamidis (Vyndamax) and acoramidis (Attruby) on the market when it won FDA approval for ...
Well, after the treatment for transthyretin cardiac amyloidosis has started, our main focus is to look at the progression of the disease. And for that, we use the combination of clinical assessment, ...
AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with transthyretin-mediated amyloidosis (ATTR), after the EMA's human medicines committee ...
Despite a sceptical appraisal by FDA reviewers, Alnylam's Onpattro has been recommended for approval as a treatment for transthyretin amyloidosis cardiomyopathy (ATTR-CM) by the regulator's advisors.
The Global ABM Conference 2025 delegate brochure is packed with all the information you'll need ahead of booking your ticket. Our second ever Global B2B Marketing Agencies Benchmarking Report is back ...
Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results